v3.25.3
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
CURRENT ASSETS:    
Cash and cash equivalents $ 2,628 $ 18,352
R&D tax credit incentive receivable 664 253
Prepaid expenses and other current assets 883 1,837
Total current assets 4,175 20,442
Property and equipment, net 2,726 1,693
Operating lease right-of-use assets, net 16,784 17,957
Restricted cash 1,338 1,338
Deposits and other assets 23 131
TOTAL ASSETS 25,046 41,561
CURRENT LIABILITIES:    
Accounts payable 1,434 817
Accrued expenses 1,978 1,803
Litigation accrual 1,675 1,675
Accrued compensation expense 357 343
Lease liability, current portion 1,386 1,348
Total current liabilities 6,830 5,986
Lease liability, noncurrent portion 16,907 17,965
TOTAL LIABILITIES 23,737 23,951
Commitments and contingencies (Note 12)
Stockholders’ equity:    
Preferred stock, par value $0.0001 per share; 10,000 shares authorized; none outstanding
Common stock, par value $0.0001 per share; 300,000 shares authorized; shares issued and outstanding: 61,511 and 59,235 at September 30, 2025 and December 31, 2024, respectively 6 6
Additional paid-in capital 143,062 139,480
Accumulated other comprehensive income 141 48
Accumulated deficit (141,900) (121,924)
TOTAL STOCKHOLDERS' EQUITY 1,309 17,610
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 25,046 $ 41,561

Source